NCT00262119View on ClinicalTrials.gov

MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

1,300

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2013

Conditions
Atrial FibrillationHeart Failure, Congestive
Interventions
DEVICE

Pacemaker Medtronic EnRhythm

Pacemaker specific programming

Trial Locations (1)

00193

Medtronic Italia S.p.A., Rome

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT00262119 - MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure | Biotech Hunter | Biotech Hunter